Generic Name ADALIMUMAB-ATTO Review Date Began Tue, 02/07/2023 - 12:00 Review Date Completed Tue, 03/21/2023 - 12:00 Conclusion PDL Product Committee Month Sat, 07/01/2023 - 12:00